Try our mobile app

Dealings in securities by an associate of a director and a director

Buy Ascendis Health Stocks
Published: 2024-01-02 18:00:57 ET [no company card] 
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)


DEALINGS IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR AND A DIRECTOR


In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the
following information regarding the dealings in securities is disclosed:

1.
 Name of director                                Theunis de Bruyn

Name of company of which the director is a       Ascendis Health Limited
director

Date of transaction                              21 December 2023

Price per security (Cents)                       79.11

Number of securities                             12 126 723

Total rand value of securities                   R9 593 450.57

Class of securities                              Ordinary shares

Nature of transaction                            Purchase of shares by an associate of the
                                                 director (on-market transaction)

Nature and extent of directors interest in the   Indirect, beneficial
transaction

Name of associate                                Calibre Investment Holdings (Pty) Ltd

Relationship with director                       Director is a director and a shareholder of
                                                 the associate


2.
Name of director                                 Karsten Wellner

Name of company of which the director is a       Ascendis Health Limited
director

Date of transaction                              28 December 2023

Price per security (Cents) (included market      78
maker spread)

Number of securities                             399 734
Total value of transaction                        R311 636.62

Class of securities                               Contracts for Difference

Nature of transaction                             Sale of Contracts for Difference by a
                                                  director (on- market transaction)

Nature and extent of directors interest in the    Direct, beneficial
transaction


Clearance for the above was obtained in terms of paragraph 3.66 of the JSE Limited Listings
Requirements.

The independent board and the board of the Company, collectively and individually, accept
responsibility for the information contained in this announcement and certify that, to the best of their
knowledge and belief, the information contained in this announcement is true and that this
announcement does not omit anything that is likely to affect the importance of such information.


Johannesburg
2 January 2024

Sponsor
Valeo Capital (Pty) Limited